Please email the editors at 'theniche at nature.com' to propose new posts.

« Can gene therapy plus liver "stem cells" cure diabetes? | Main | Clinical trials mentioning stem cells up over 200% from summer 2007 »

Bookmark in Connotea

Stem-cell tourism, what's a scientist to do?

Members of the scientific community should lobby regulatory authorities to regulate bogus stem-cell clinics, according to the latest policy forum in Science this week (subscription required). The piece calls out the claims and (lack of) evidence put forward by stem-cell clinics in countries “not known as leaders in biomedical research.”

The forum also urges the World Health Organisation to create a consensus statement on the clinical application of stem cell research. Individual scientists should help provide non-English translations of existing information, such as the patient handbook developed by the International Society for Stem Cell Research, which includes questions would-be stem cell tourists should ask clinics and physicians.

The authors of the forum, Doug Sipp of Japan’s RIKEN and Kyoto University and physician Sorapop Kiatpongsan of Chulalongkorn University of Bangkok and Harvard, published an earlier commentary with Nature Reports, in which they analysed the duties and motivations of patients, physicians, scientists, governments, and other stakeholders that act in this arena.

Though stem cell tourism operates outside the scientific mainstream, stem-cell scientists should care about it not just because patients can be harmed but because mishaps can cause mistrust of those clinicians who are struggling to meet regulatory requirements and established guidelines to move stem cell research to the clinic.

Here are some of our articles reporting on stem cell tourism and the scientific community’s actions and reactions toward it.

Stem cell researchers face down stem cell tourism
A variety of international efforts hope to warn patients off unregulated treatments

Stick to the guidelines and fewer get hurt
The ISSCR hopes its handbook will prompt regulators and governments to shut shady clinics

Unregulated stem cell transplant causes tumours
Researchers say cells were poorly characterized prior to transplantation

Stem cell clinical trials must be closely monitored
Results of unregulated stem cell transplant were predictable and avoidable

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/7755

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'theniche at nature.com'.

please enter code